Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. - Powerful Science for Life™
$5M credit facility with expected $20M revenues, $2-3M earnings, $60-90M cap and NASDAQ listing.
ARYC @Arrayit ARYC is getting ready to be a monster!! PPS at .0012.......Market Cap of just over $1 million...... Subsidiary of ARYC, AVDX,now at .32 puts ARYC's 40mm share ownership at $22 mm, alone. ..... Yet market cap is currently at $1million???!!!!????!!!! But this is what is going to blow share prices out of the water: @Arrayit is on track for all time record revenues this year!
function and diagnostics. Using Arrayit’s proprietary and patented technologies, the Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping, gene expression and protein analysis markets, and the Company expects to enter the market for manufacturing molecular diagnostics.
Arrayit has earned respect as a leader in the health care and life sciences industries with its proven expertise in three key areas: the development and support of microarray tools and components, custom printing and analysis of microarrays for research, and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states. As a result, Arrayit has provided tools and services to thousands of the leading genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies worldwide.
News just out!!
Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.